Page last updated: 2024-09-04

leonurine and Osteoporosis, Postmenopausal

leonurine has been researched along with Osteoporosis, Postmenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, XL; Jiang, DL; Jin, C; Li, X; Su, Q; Xu, RS; Yuan, FL	1

Other Studies

1 other study(ies) available for leonurine and Osteoporosis, Postmenopausal

Article	Year
Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways. Bone, 2015, Volume: 75 Topics: Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Female; Fluorescent Antibody Technique; Gallic Acid; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction	2015

Article

Year

Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.

Bone, 2015, Volume: 75

Topics: Animals; Blotting, Western; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Electrophoretic Mobility Shift Assay; Female; Fluorescent Antibody Technique; Gallic Acid; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2015